{"protocolSection":{"identificationModule":{"nctId":"NCT04312269","orgStudyIdInfo":{"id":"SP0052149"},"organization":{"fullName":"Northwestern University","class":"OTHER"},"briefTitle":"Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke","officialTitle":"Combining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke"},"statusModule":{"statusVerifiedDate":"2023-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-02-25","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-11-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-11-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-03-09","studyFirstSubmitQcDate":"2020-03-16","studyFirstPostDateStruct":{"date":"2020-03-18","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-04-19","lastUpdatePostDateStruct":{"date":"2023-04-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Marc Slutzky","investigatorTitle":"Associate Professor","investigatorAffiliation":"Northwestern University"},"leadSponsor":{"name":"Northwestern University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Sleep"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","maskingDescription":"Outcomes assessors and participant are blinded to groups.","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":70,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"All phase TMR","type":"EXPERIMENTAL","description":"TMR during every stage of sleep","interventionNames":["Other: Targeted Memory Reactivation (TMR)"]},{"label":"Slow-wave sleep (SWS) only TMR","type":"EXPERIMENTAL","description":"TMR during slow-wave sleep only","interventionNames":["Other: Targeted Memory Reactivation (TMR)"]},{"label":"Reduced frequency TMR","type":"EXPERIMENTAL","description":"TMR during only subset of sessions","interventionNames":["Other: Targeted Memory Reactivation (TMR)"]},{"label":"Sham TMR","type":"SHAM_COMPARATOR","description":"Patients receive no TMR","interventionNames":["Other: Targeted Memory Reactivation (TMR)"]}],"interventions":[{"type":"OTHER","name":"Targeted Memory Reactivation (TMR)","description":"Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep.","armGroupLabels":["All phase TMR","Reduced frequency TMR","Sham TMR","Slow-wave sleep (SWS) only TMR"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Wolf Motor Function Test (WMFT)","description":"The WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task.","timeFrame":"change from baseline at 6 weeks"}],"secondaryOutcomes":[{"measure":"Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function","description":"The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.","timeFrame":"change from baseline at 6 weeks"},{"measure":"Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function","description":"The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.","timeFrame":"change from baseline at 10 weeks"},{"measure":"Motor Activity Log (MAL)","description":"The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.","timeFrame":"change from baseline at 6 weeks"},{"measure":"Motor Activity Log (MAL)","description":"The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.","timeFrame":"change from baseline at 10 weeks"},{"measure":"Modified Ashworth Scale","description":"The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.","timeFrame":"change from baseline at 6 weeks"},{"measure":"Modified Ashworth Scale","description":"The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.","timeFrame":"change from baseline at 10 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age at enrollment is 21 or older\n* Hemiparesis from first ever stroke affecting arm movement at least 6 months prior to screening\n* Severe to moderate motor impairment (FMA-UE of 7-40)\n* At least some voluntary shoulder and elbow muscle activation\n\nExclusion Criteria:\n\n* Inability to follow instructions of the MyoCI task\n* Visual impairment (such as hemianopia) preventing full view of screen\n* Anesthesia or neglect in the affected arm, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest)\n* Participation in another study on the affected arm within 6 weeks of enrollment or any pharmacological study\n* Inability to understand or follow commands in English due to aphasia or other reason\n* Diffuse or multifocal infarcts in both hemispheres\n* Substantial arm pain preventing participation for 90 minutes a day\n* Spasticity treatment (pharmacological or Botox) within last 3 months\n* Ferromagnetic implants that are MRI incompatible","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Marc W Slutzky, MD/PhD","role":"CONTACT","phone":"312-503-4653","email":"mslutzky@northwestern.edu"}],"overallOfficials":[{"name":"Marc W Slutzky, MD/PhD","affiliation":"Northwestern University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Northwestern University","status":"RECRUITING","city":"Chicago","state":"Illinois","zip":"60611","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]}},"hasResults":false}